- Eco-friendly controlled-release crop protection film
for active pest, weed and fungi control
- Serves as broad-spectrum soil treatment, replacing the need
for pre-plant soil fumigation
- Significantly lowers pesticide use, diminishing the
potential risk to human health and the environment, while also
enhancing grower efficiencies
- ADVASEAL® offers a compelling business
opportunity
MONTRÉAL, Nov. 7, 2022
/CNW Telbec/ - Imaflex Inc. ("Imaflex" or the "Corporation") (TSXV:
IFX) announces that it has submitted the ADVASEAL
HG® (ADVASEAL®) registration package to
the U.S. Environmental Protection Agency (EPA) for approval as a
new physical pesticide formulation. In conjunction with this, the
Corporation submitted the required active ingredient
(TGAI1) registrations for approval as generic pesticides
for use in the manufacturing of ADVASEAL®.
Today's news follows the successful completion of two previously
announced independent field trials – the Efficacy Trial and the
Release Study – which respectively demonstrated the efficacy and
safety of ADVASEAL® as a pre-plant soil fumigant
replacement. "If approved, ADVASEAL® will provide fruit
and vegetable growers with a more efficient, less costly, and more
ecologically friendly delivery platform of pre-plant crop
protection products," highlighted Mr. Joe
Abbandonato, President and Chief Executive Officer of
Imaflex.
The required active ingredient rates using ADVASEAL®
are more than 95% lower than the current labeled fumigant rates per
acre and the exposure to emissions and pesticide drift is almost
eliminated for applicators and bystanders. "With a heightened
global move towards more sustainable practices,
ADVASEAL® offers considerable market opportunity, along
with crop protection profitability margins," continued Mr.
Abbandonato.
Management believes the EPA registration process will be
positive as the generic pesticides to be used in
ADVASEAL® are effectively used by growers today.
As well, the Corporation previously received EPA approval of an
herbicidal active ingredient release film, ADVASEAL®
HSM.
________________________________
|
1 A
technical grade active ingredient ("TGAI") is used for the
manufacturing of pesticide end-use products and contains, in
addition to the pure active ingredient, minor amounts of
impurities.
|
About ADVASEAL®
Today, agricultural films are used in the growing of vegetables
worldwide to cover soil treated with fumigants – volatile and toxic
pesticides essential for reducing pests, weeds and fungi in the
soil, thus supporting good growth of new crop seedlings.
The original EPA approved ADVASEAL® HSM, contained
only an herbicide for weed control. The new enhanced ADVASEAL
HG® (ADVASEAL®) also includes fungicides
and a nematicide to control soil borne pathogens, thus becoming a
complete non-fumigant alternative for soil disinfestation. With
ADVASEAL®, modern non-volatile crop protection products
can be applied more effectively and safely than with fumigants. The
active ingredients are incorporated into a coating, which is then
applied to a mulch film. Once the coated film is applied to the
ground, the crop protection products are released into the soil
under controlled conditions. This new technology dramatically
reduces the amount of pre-plant crop protection products required.
The catalyst to trigger the release of the active ingredients is
soil moisture. When the film is applied to the soil, they are
efficiently and safely discharged into the ground, resulting in
heightened productivity, lower costs and notable environmental
benefits.
About Imaflex Inc.
Founded in 1994, Imaflex is focused on the development and
manufacturing of innovative solutions for the flexible packaging
space. Concurrently, the Corporation develops and
manufactures films for the agriculture industry. The Corporation's
products consist primarily of polyethylene (plastic) film and bags,
including metalized plastic film, for the industrial, agricultural
and consumer markets. Headquartered in Montreal, Quebec, Imaflex has manufacturing
facilities in Canada and
the United States. The
Corporation's common stock is listed on the TSX Venture Exchange
under the ticker symbol IFX. Additional information is
available at www.imaflex.com.
Cautionary Statement on Forward Looking
Information
Certain information included in this press release
constitutes "forward-looking" statements within the meaning of
Canadian securities laws. Forward-looking statements are
necessarily based upon a number of estimates and assumptions that,
while considered reasonable by the management of the Corporation,
are inherently subject to significant business, economic and
competitive uncertainties, risks and contingencies. The Corporation
cautions the reader that such forward-looking statements involve
known and unknown risks, uncertainties and other factors that may
cause the actual financial results, performance or achievements of
Imaflex to be materially different from the Corporation's estimated
future results, performance or achievements expressed or implied by
those forward-looking statements and that the forward-looking
statements are not guarantees of future performance. These
statements are also based on certain factors and assumptions. For
more details on these estimates, risks, assumptions and factors,
see the Corporation's most recent Management Discussion and
Analysis filed on SEDAR at www.sedar.com and on the investor
section of the Corporation's website at www.imaflex.com. The
Corporation disclaims any obligation to update or revise any
forward-looking statements, whether as a result of new information,
events or otherwise, except as expressly required by law. Readers
are cautioned not to put undue reliance on these forward-looking
statements.
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Imaflex Inc.